News Search Results
Mar 12, 2025, 14:15 ET Global Markets for 3D Cultures and Organoids: Trends Analysis with Forecast
2029, at a CAGR of 12.7% during the forecast period. Market leaders include: • 3D Biotek LLC • Bio-Techne • Cellink • Charles River Laboratories • Cherry Biotech • Corning Inc. •
More news about: BCC Research LLC
Mar 10, 2025, 07:00 ET Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System
MINNEAPOLIS, March 10, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has begun shipping the Leo™ System, powered by Simple Western™ Technology. Leo expands upon existing
More news about: Bio-Techne Corporation
Mar 03, 2025, 17:31 ET Global In Situ Hybridization Market to Grow at a CAGR of ~7% by 2032 | DelveInsight
Biocare Medical, LLC, Genemed Biotechnologies, Inc., NeoGenomics Laboratories, Advanced Cell Diagnostics, Inc., BioView, Bio-Rad Laboratories, Inc., Bio-Techne, QIAGEN, BioGenex, ZYTOVISION GmbH, Promega Corporation, Illumina, Inc., Danaher Corporation, and several others, are currently operating in the
More news about: DelveInsight Business Research, LLP
Mar 03, 2025, 07:00 ET Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
[email protected] About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Feb 27, 2025, 07:00 ET Bio-Techne to Present at Investor Conferences
https://investors.bio-techne.com/ir-calendar. About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Feb 21, 2025, 06:22 ET Weekly Roundup: 15 Health Press Releases You Need to See
Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering SystemThe TcBuster System has been widely used by researchers
More news about: PR Newswire
Feb 20, 2025, 07:00 ET Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
and ultimately improve lives." About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Feb 18, 2025, 07:00 ET Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
website or contact us directly. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Feb 05, 2025, 06:30 ET Bio-Techne Declares Dividend
considered by the Board of Directors on a quarterly basis. Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes
More news about: Bio-Techne Corporation
Feb 05, 2025, 06:30 ET Bio-Techne Releases Second Quarter Fiscal 2025 Results
measures is included in this press release. "The Bio-Techne team once again executed at a high level and delivered strong second quarter results," said Kim Kelderman, President and Chief Executive Officer of Bio-Techne. "It is encouraging to see early signs of improvement
More news about: Bio-Techne Corporation
Feb 05, 2025, 01:52 ET Exosome Diagnostics & Therapeutics Market to Grow by USD 1.01 Billion (2025-2029) with Rising Research in Exosome Therapeutics Boosting the Market, Report on How AI is Driving Market Transformation - Technavio
exosome collection. However, strict regulatory approval for product launches poses a challenge. Key market players include Aethlon Medical Inc., Bio Techne Corp., BioCat GmbH, BioVision Inc., Capricor Therapeutics Inc., Cell Guidance Systems Ltd., Clara Biotech Inc., Evox Therapeutics Ltd., HansaBioMed
More news about: Technavio
Feb 04, 2025, 07:00 ET Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
Board of Bio-Techne. "She brings tremendous scientific experience to Bio-Techne. For example, Dr. Herr's extensive bioengineering background brings an important skillset as the Company continues to grow its proteomic analytical instrument business." About Bio-TechneBio-Techne Corporation
More news about: Bio-Techne Corporation
Jan 23, 2025, 10:15 ET Gene Transfer Technologies Market to Hit US$5.93 Billion by 2029 with 9.7% CAGR | MarketsandMarkets™
Sartorius AG (Germany), Bio-Rad Laboratories Inc. (US), Revvity (US), Agilent Technologies, Inc (US), Genscript (US) and Bio-Techne (US) and among others. Thermo Fisher Scientific is one of the leaders in gene transfer technologies with extensive product range. The
More news about: MarketsandMarkets
Jan 21, 2025, 07:00 ET Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results
Wednesday, March 5, 2025. About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Jan 21, 2025, 07:00 ET ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio
G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation
Jan 17, 2025, 06:32 ET Weekly Roundup: 15 Health Press Releases You Need to See
Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative MedicineThese innovative
More news about: PR Newswire
Jan 16, 2025, 20:55 ET Fetal Bovine Serum Market to Grow by USD 364.2 Million (2025-2029), Driven by Stem Cell Adoption; AI-Powered Market Evolution - Technavio
pharmaceutical research. However, volatility in prices of fbs poses a challenge. Key market players include Animal Technologies Inc., Atlas Biologicals Inc., Bio Techne Corp., Celtic Molecular Diagnostics, Corning Inc., Danaher Corp., GeminiBio, GeneTex Inc., Grifols SA, HiMedia Laboratories Pvt. Ltd., Itoham Yonekyu
More news about: Technavio
Jan 13, 2025, 10:30 ET Spatial Genomics & Transcriptomics Market to Hit USD 995.7 Million by 2029 with 12.4% CAGR | MarketsandMarkets™
work and possible therapeutic targets. These products are not directly competing with other spatial platform technologies. Bio-Techne (US) Bio-Techne is well-known for its RNAscope technology in the framework of spatial genomics and transcriptomics since it enables single-molecule
More news about: MarketsandMarkets
Jan 10, 2025, 07:00 ET Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
website. About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Jan 08, 2025, 10:30 ET Cell Therapy Technologies Market to Hit US$ 6.80 Billion by 2029 with 11.0% CAGR | MarketsandMarkets™
Switzerland), Sartorius AG (Germany), Agilent Technologies Inc. (US), Avantor, Inc. (US), Bio-Techne (US), Avantor, Inc. (US), Fresenius SE & Co KGAA (Germany), BD (US), Corning Incorporated (US) and among others.
More news about: MarketsandMarkets
Jan 08, 2025, 07:00 ET BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
David Hermanson, Ph.D. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Jan 08, 2025, 07:00 ET ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics
G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation
Jan 07, 2025, 12:55 ET Global Market for Cell and Gene Therapy Tools and Reagents Projected to Grow at a 10.8% CAGR
ABCAM LTD.ADVERUM BIOTECHNOLOGIES INC.AKRON BIOTECHBIO-RAD LABORATORIES INC.BIO-TECHNECYTIVAFUJIFILM IRVINE SCIENTIFICMILTENYI BIOTECPROTEINTECH GROUP INC.QIAGENREVVITYSARTORIUS
More news about: BCC Research LLC
Jan 07, 2025, 07:00 ET BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
ruling. About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific
More news about: Bio-Techne Corporation
Dec 20, 2024, 07:00 ET BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
https://investors.bio-techne.com/ir-calendar. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation